Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial
About this study
This is a pilot study designed to evaluate the effectiveness of continuous glucose monitoring (CGM) within hours of delivery to predict long-term risk of Type 2 Diabetes Mellitus in patients diagnosed with gestational diabetes. Participants will be provided a CGM within 2 hours after delivery and wear the device for 24 hours. Participants will be instructed to peel off the device after 24 hours. Participants will also be asked to complete two surveys regarding their experience at 1-3 months postpartum and 12-14 months postpartum.
- Condition
- Gestational Diabetes Mellitus in Pregnancy
- Tested
- Continuous Glucose Monistor
- Sponsor
- University of California, Los Angeles
Who can join
- Age
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
Inclusion 7
- Minimum age: 18 years
- Eligible sex: Female
- Study condition: Gestational Diabetes Mellitus in Pregnancy
- Prenatal care at UCLA Health
- Planning to deliver at UCLA Ronald Reagan or UCLA Santa Monica
- Confirmed gestational diabetes diagnosis based on 2-step approach
- Maternal age \>= 18 years
Exclusion 13
- Pre-gestational diabetes (T1DM or T2DM)
- Multifetal gestation
- Intra-amniotic infection by clinical criteria
- Postpartum hemorrhage
- Maternal ICU admission
- Known allergy to medical-grade adhesive
- Presence of skin lesions at anticipated CGM application site
- Scheduled postpartum non-sonographic imaging study (radiograph, magnetic resonance imaging (MRI), or computed tomography (CT) scan) during trial
- Metformin use
- Steroid use
- Terbutaline use within 4 hours of delivery
- Cystic fibrosis
- MODY (mature onset of diabetes in the young)
Where
1 site, 1 recruiting
University of California, Los Angeles
Los Angeles, California, United States
Contact
-
Rujuta Sathe
310-794-8893 RSathe@mednet.ucla.edu
-
Dana Levin-Lopez, MPH
310-794-8893 dlevinlopez@mednet.ucla.edu
Potential match only. Final eligibility is determined by the study team.